202 related articles for article (PubMed ID: 27355345)
21. Alternative methylation of intron motifs is associated with cancer-related gene expression in both canine mammary tumor and human breast cancer.
Nam AR; Lee KH; Hwang HJ; Schabort JJ; An JH; Won SH; Cho JY
Clin Epigenetics; 2020 Jul; 12(1):110. PubMed ID: 32693820
[TBL] [Abstract][Full Text] [Related]
22. Genome-wide analysis of aberrant methylation in human breast cancer cells using methyl-DNA immunoprecipitation combined with high-throughput sequencing.
Ruike Y; Imanaka Y; Sato F; Shimizu K; Tsujimoto G
BMC Genomics; 2010 Feb; 11():137. PubMed ID: 20181289
[TBL] [Abstract][Full Text] [Related]
23. Methylome and transcriptome analyses reveal insights into the epigenetic basis for the good survival of hypomethylated ER-positive breast cancer subtype.
Chen XQ; Zhang F; Su QC; Zeng C; Xiao FH; Peng Y
Clin Epigenetics; 2020 Jan; 12(1):16. PubMed ID: 31959227
[TBL] [Abstract][Full Text] [Related]
24. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic regulation of cancer stem cell genes in triple-negative breast cancer.
Kagara N; Huynh KT; Kuo C; Okano H; Sim MS; Elashoff D; Chong K; Giuliano AE; Hoon DS
Am J Pathol; 2012 Jul; 181(1):257-67. PubMed ID: 22626806
[TBL] [Abstract][Full Text] [Related]
26. Impact of mutations in DNA methylation modification genes on genome-wide methylation landscapes and downstream gene activations in pan-cancer.
Lee CJ; Ahn H; Jeong D; Pak M; Moon JH; Kim S
BMC Med Genomics; 2020 Feb; 13(Suppl 3):27. PubMed ID: 32093698
[TBL] [Abstract][Full Text] [Related]
27. DNA methylation data for identification of epigenetic targets of resveratrol in triple negative breast cancer cells.
Medina-Aguilar R; Pérez-Plasencia C; Gariglio P; Marchat LA; Flores-Pérez A; López-Camarillo C; García Mena J
Data Brief; 2017 Apr; 11():169-182. PubMed ID: 28229117
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic Effects of Resveratrol on Oncogenic Signaling in Breast Cancer.
Kurzava Kendall L; Ma Y; Yang T; Lubecka K; Stefanska B
Nutrients; 2024 Feb; 16(5):. PubMed ID: 38474826
[TBL] [Abstract][Full Text] [Related]
29. Comparative genome-wide DNA methylation analysis of colorectal tumor and matched normal tissues.
Simmer F; Brinkman AB; Assenov Y; Matarese F; Kaan A; Sabatino L; Villanueva A; Huertas D; Esteller M; Lengauer T; Bock C; Colantuoni V; Altucci L; Stunnenberg HG
Epigenetics; 2012 Dec; 7(12):1355-67. PubMed ID: 23079744
[TBL] [Abstract][Full Text] [Related]
30. Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors.
Neumann O; Kesselmeier M; Geffers R; Pellegrino R; Radlwimmer B; Hoffmann K; Ehemann V; Schemmer P; Schirmacher P; Lorenzo Bermejo J; Longerich T
Hepatology; 2012 Nov; 56(5):1817-27. PubMed ID: 22689435
[TBL] [Abstract][Full Text] [Related]
31. Using Illumina Infinium HumanMethylation 450K BeadChip to explore genome‑wide DNA methylation profiles in a human hepatocellular carcinoma cell line.
Sun N; Zhang J; Zhang C; Shi Y; Zhao B; Jiao A; Chen B
Mol Med Rep; 2018 Nov; 18(5):4446-4456. PubMed ID: 30221710
[TBL] [Abstract][Full Text] [Related]
32. Association of leukocyte DNA methylation changes with dietary folate and alcohol intake in the EPIC study.
Perrier F; Viallon V; Ambatipudi S; Ghantous A; Cuenin C; Hernandez-Vargas H; Chajès V; Baglietto L; Matejcic M; Moreno-Macias H; Kühn T; Boeing H; Karakatsani A; Kotanidou A; Trichopoulou A; Sieri S; Panico S; Fasanelli F; Dolle M; Onland-Moret C; Sluijs I; Weiderpass E; Quirós JR; Agudo A; Huerta JM; Ardanaz E; Dorronsoro M; Tong TYN; Tsilidis K; Riboli E; Gunter MJ; Herceg Z; Ferrari P; Romieu I
Clin Epigenetics; 2019 Apr; 11(1):57. PubMed ID: 30940212
[TBL] [Abstract][Full Text] [Related]
33. Trans-resveratrol alters mammary promoter hypermethylation in women at increased risk for breast cancer.
Zhu W; Qin W; Zhang K; Rottinghaus GE; Chen YC; Kliethermes B; Sauter ER
Nutr Cancer; 2012 Apr; 64(3):393-400. PubMed ID: 22332908
[TBL] [Abstract][Full Text] [Related]
34. Methyl-CpG-binding protein MBD2 plays a key role in maintenance and spread of DNA methylation at CpG islands and shores in cancer.
Stirzaker C; Song JZ; Ng W; Du Q; Armstrong NJ; Locke WJ; Statham AL; French H; Pidsley R; Valdes-Mora F; Zotenko E; Clark SJ
Oncogene; 2017 Mar; 36(10):1328-1338. PubMed ID: 27593931
[TBL] [Abstract][Full Text] [Related]
35. Constitutive expression of AhR and BRCA-1 promoter CpG hypermethylation as biomarkers of ERα-negative breast tumorigenesis.
Romagnolo DF; Papoutsis AJ; Laukaitis C; Selmin OI
BMC Cancer; 2015 Dec; 15():1026. PubMed ID: 26715507
[TBL] [Abstract][Full Text] [Related]
36. Comparison of genome-wide analysis techniques to DNA methylation analysis in human cancer.
Soozangar N; Sadeghi MR; Jeddi F; Somi MH; Shirmohamadi M; Samadi N
J Cell Physiol; 2018 May; 233(5):3968-3981. PubMed ID: 28888056
[TBL] [Abstract][Full Text] [Related]
37. DNA methylation and repressive H3K9 and H3K27 trimethylation in the promoter regions of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, and PD-L1 genes in human primary breast cancer.
Sasidharan Nair V; El Salhat H; Taha RZ; John A; Ali BR; Elkord E
Clin Epigenetics; 2018; 10():78. PubMed ID: 29983831
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73.
van Doorn R; Zoutman WH; Dijkman R; de Menezes RX; Commandeur S; Mulder AA; van der Velden PA; Vermeer MH; Willemze R; Yan PS; Huang TH; Tensen CP
J Clin Oncol; 2005 Jun; 23(17):3886-96. PubMed ID: 15897551
[TBL] [Abstract][Full Text] [Related]
39. Determining the effect of DNA methylation on gene expression in cancer cells.
Lee CJ; Evans J; Kim K; Chae H; Kim S
Methods Mol Biol; 2014; 1101():161-78. PubMed ID: 24233782
[TBL] [Abstract][Full Text] [Related]
40. Rare and frequent promoter methylation, respectively, of TSHZ2 and 3 genes that are both downregulated in expression in breast and prostate cancers.
Yamamoto M; Cid E; Bru S; Yamamoto F
PLoS One; 2011 Mar; 6(3):e17149. PubMed ID: 21423795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
